Acrivon Therapeutics, Inc. Shares Outstanding (Cover Page)
Acrivon Therapeutics, Inc. (ACRV) had Shares Outstanding (Cover Page) of 42.85 million shares as of 2026-08-07, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-12
- 2026-08-07: Entity Common Stock, Shares Outstanding 42.85M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 42.80M shares.
- 2026-03-16: Entity Common Stock, Shares Outstanding 38.74M shares.
- 2025-11-07: Entity Common Stock, Shares Outstanding 31.56M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-07 | 42.85M shares 10-Q · filed 2026-08-12 |
| 2026-05-08 | 42.80M shares 10-Q · filed 2026-05-13 |
| 2026-03-16 | 38.74M shares 10-K · filed 2026-03-19 |
| 2025-11-07 | 31.56M shares 10-Q · filed 2025-11-13 |
| 2025-08-08 | 31.46M shares 10-Q · filed 2025-08-13 |
| 2025-05-09 | 31.36M shares 10-Q · filed 2025-05-14 |
| 2025-03-24 | 31.35M shares 10-K · filed 2025-03-27 |
| 2024-11-07 | 31.14M shares 10-Q · filed 2024-11-13 |
| 2024-08-08 | 30.97M shares 10-Q · filed 2024-08-13 |
| 2024-05-09 | 30.88M shares 10-Q · filed 2024-05-14 |
| 2024-03-25 | 22.64M shares 10-K · filed 2024-03-28 |
| 2023-11-03 | 22.19M shares 10-Q · filed 2023-11-09 |
| 2023-08-08 | 22.07M shares 10-Q · filed 2023-08-11 |
| 2023-05-04 | 21.93M shares 10-Q · filed 2023-05-09 |
| 2023-03-24 | 21.92M shares 10-K · filed 2023-03-28 |
| 2022-12-09 | 20.88M shares 10-Q · filed 2022-12-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rallybio Corp (RLYB) | United States | $0.089B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |